TRAF3 and head and neck cancer: Indeed, we found that experimental TRAF3 and CYLD inactivation was sufficient to strikingly sensitize HPV+ head and neck cancer cells to radiation, as well as promote increased expression of well-known NF-κB targets and sky blue (NF-κB) module genes (Fig. 8 A–E).